What Does It Mean?
Congestive Heart Failure (CHF) is a chronic, progressive condition in which the heart is unable to pump blood efficiently, leading to fluid buildup in the lungs and other tissues. CHF is often associated with hypertension, coronary artery disease, and cardiomyopathy. The dysfunction results in decreased oxygen delivery to organs, reduced exercise tolerance, and increased systemic inflammation.
How Did We Get There?
Root Causes:
• Hypertension & Atherosclerosis – Chronic high blood pressure increases the workload on the heart, leading to myocardial damage.
• Mitochondrial Dysfunction – Reduced ATP production weakens cardiac muscle function.
• Chronic Inflammation & Oxidative Stress – Elevated inflammatory markers contribute to endothelial dysfunction and vascular damage.
• Nutrient Deficiencies – Low levels of CoQ10, magnesium, and omega-3 fatty acids impair cardiac energy metabolism.
• Poor Circulation & Endothelial Dysfunction – Impaired nitric oxide synthesis reduces blood vessel dilation, exacerbating CHF symptoms.
• Toxic Load & Heavy Metals – Environmental toxins such as lead and mercury have been linked to increased cardiovascular risk.
• Hormonal Dysregulation – Thyroid dysfunction and adrenal imbalances can exacerbate CHF progression.
Signs & Symptoms:
• Shortness of breath (dyspnea), especially when lying down
• Fatigue and reduced exercise tolerance
• Swelling in the legs, ankles, and feet (edema)
• Rapid or irregular heartbeat (arrhythmias)
• Persistent cough or wheezing with white or pink mucus
• Weight gain due to fluid retention
• Decreased urine output and kidney dysfunction
Lab Test Findings
| Lab Test Name | Expected Changes | Optimal Range |
| Albumin: Globulin Ratio | Altered | 1.00-2.50 |
| Arachidonic Acid (AA) | Altered | 8.6-15.6 µg/mL |
| Basophil Absolute Count | Increased | 0.00-0.07 (10³/uL) |
| Coenzyme Q10 | Decreased | 0.35-2.20 µg/mL |
| Docosahexaenoic Acid (DHA) | Decreased | 1.2-3.9 µg/mL |
| Docosapentaenoic acid (DPA) | Decreased | 0.8-1.8 µg/mL |
| Eicosapentaenoic Acid (EPA) | Decreased | 0.2-2.3 µg/mL |
| Ferritin | Increased | 45.00-79.00 µg/mL |
| Omega-6 : Omega-3 Ratio | Increased | 3.7-14.4 |
| Platelet : Lymphocyte (PLR) Ratio | Increased | 0.00-128.00 |
| ProBNP (B-type Natriuretic Peptide) | Increased | 0.00-100.00 pg/mL |
| Sodium | Decreased | 137.00-142.00 mEq/L |
| Troponin T (Highly Sensitive) | Increased | 0.00-22.00 ng/mL |
How Do We Treat It?
Supplement Protocol
| Supplement | Function | Dosage & Frequency |
| Magnesium | Supports vascular relaxation and reduces blood pressure | 2 capsules with or without food, daily |
| CitraNOX | Enhances nitric oxide synthesis to improve circulation | 2 capsules with food, daily |
| VesselMax | Promotes blood vessel health and reduces inflammation | 3 capsules with food, daily |
| V-Pax | Provides mitochondrial support for cardiac energy metabolism | 2 capsules with food, twice daily |
| CoQ-10 300 mg | Supports ATP production and cardiac muscle function | 1 capsule with food, daily |
| Vita-Omega | Provides essential omega-3 fatty acids for cardiovascular support | 2 capsules with food, daily |
| Vita-D | Supports endothelial function and immune health | 1 capsule with food, daily |
| RegeneVasc | Improves microvascular circulation and reduces oxidative stress | 2 capsules with food, daily |
Additional Lifestyle Interventions:
• Adopt a Heart-Healthy Diet: Emphasize whole foods, healthy fats, and lean proteins while reducing sodium and processed foods.
• Exercise Moderately: Engage in low-impact cardiovascular activities such as walking or swimming to improve circulation.
• Monitor Fluid Intake: Regulate hydration levels to prevent fluid overload and maintain electrolyte balance.
• Reduce Stress: Implement relaxation techniques such as meditation and deep breathing exercises to lower cortisol levels.
• Avoid Toxins: Minimize exposure to environmental pollutants, smoking, and heavy metals.
• Manage Blood Sugar: Maintain stable glucose levels through balanced meals to prevent further vascular damage.